METHOD AND SYSTEM FOR DETERMINING WHETHER A DRUG WILL BE EFFECTIVE ON A PATIENT WITH A DISEASE

Patent №

US 8,097,469

Granted

2012-01-17

Filed 2010

Owner

BIODESIX INC.

Lab

AI components

2

ml · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

12661124

A process of determining whether a patient with a disease or disorder will be responsive to a drug, used to treat the disease or disorder, including obtaining a test spectrum produced by a mass spectrometer from a serum produced from the patient. The test spectrum may be processed to determine a relation to a group of class labeled spectra produced from respective serum from other patients having the or similar clinical stage same disease or disorder and known to have responded or not responded to the drug. Based on the relation of the test spectrum to the group of class labeled spectra, a determination may be made as to whether the patient will be responsive to the drug.

Machine learningAI hardwareG16B 40/00A61P 35/00G06F 18/2115G06F 18/24147G06V 20/69G16B 40/20G06V 2201/03G16B 20/00+2 more

AI classification

AI hardware0.87
Machine learning0.62
Vision0.10
Natural language0.00
Evolutionary computation0.00
Knowledge representation0.00
Planning0.00
Speech0.00

Ownership

BIODESIX INC.

assignment · 448150155

Assignors

RODER, HEINRICH, TSYPIN, MAXIM, GRIGORIEVA, JULIA

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC